Pure Global

Effect of Heatwaves on Glycemic Control in People With Type 1 Diabetes Treated With Artificial Pancreas - Trial NCT06214780

Access comprehensive clinical trial information for NCT06214780 through Pure Global AI's free database. This phase not specified trial is sponsored by Castilla-La Mancha Health Service and is currently Recruiting. The study focuses on Type 1 Diabetes. Target enrollment is 300 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06214780
Recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT06214780
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Effect of Heatwaves on Glycemic Control in People With Type 1 Diabetes Treated With Artificial Pancreas
Effect of Heatwaves on Glycemic Control in Adult Patients With Type 1 Diabetes Mellitus Treated With Advanced Hybrid Closed Loop Systems

Study Focus

Type 1 Diabetes

advanced hybrid closed-loop

Observational

device

Sponsor & Location

Castilla-La Mancha Health Service

Alcรกzar De San Juan,Puertollano,Valdepeรฑas,Talavera De La Reina,Albacete,Ciudad Real,Cuenca,Guadalajara,Toledo, Spain

Timeline & Enrollment

N/A

Jan 22, 2024

May 31, 2024

300 participants

Primary Outcome

Change in time in range

Summary

To analyze the effect of heatwaves on interstitial glucose in adult patients with type 1
 diabetes mellitus treated with artificial pancreas

ICD-10 Classifications

Type 1 diabetes mellitus
Type 1 diabetes mellitus without complications
Type 1 diabetes mellitus with unspecified complications
Type 1 diabetes mellitus with other specified complications
Type 1 diabetes mellitus with multiple complications

Data Source

ClinicalTrials.gov

NCT06214780

Device Trial